+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Regenerative Medicine Market - By Technology (Cell Therapy, Tissue Engineering, Gene Therapy), Region (North America [US], Europe [UK], Asia Pacific [Japan]) Market Outlook 2025

  • ID: 4773486
  • Report
  • May 2019
  • Region: Global, North America, Europe, Asia Pacific
  • 74 Pages
  • Rockville Research
1 of 3

FEATURED COMPANIES

  • Merck & Co. Inc.
  • MiMedx Group Inc.
  • Organogenesis Inc.
  • Stryker Corporation
  • Vericell Corporation
  • MORE

Utilization of nanomaterial for tissue generation has created avenues for a new realm of advancement in the field of regenerative medicine. It has facilitated control of biochemical and mechanical microenvironment for successful cell delivery and tissue regeneration especially in wound care, drug delivery, and immunomodulation.

The report “Global Regenerative Medicine Market By Technology – Cell Therapy, Tissue Engineering & Gene Therapy; By Region – North America (The US), Europe (The UK) & Asia Pacific (Japan) Market Outlook 2025” provides in-depth analysis of the current scenario, detailed market outlook of the global regenerative medicine market overall as well as across various therapies such as Cell Therapy, Gene Therapy and Tissue Engineering. Regional analysis is done across major markets in North America, Europe, and Asia Pacific.

The report provides comprehensive coverage on major industry drivers, restraints, and their impact on market growth during the forecast period. Furthermore, the study encompasses various market-specific growth opportunities in the global regenerative medicine market. The report has been segmented as follows:-

Geographical Coverage

  • North America: the US
  • Europe: the UK
  • Asia Pacific: Japan

Key Vendors

  • Integra LifeSciences Corporation
  • Merck & Co., Inc.
  • Stryker Corporation
  • Organogenesis Inc.
  • Vericell Corporation
  • MiMedx Group
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Merck & Co. Inc.
  • MiMedx Group Inc.
  • Organogenesis Inc.
  • Stryker Corporation
  • Vericell Corporation
  • MORE

1. Executive Summary

2. Research Methodology

3. Regenerative Medicine
3.1 Overview
3.1.1 Mechanism of Action
3.2 Therapies
3.2.1 Cell Therapy
3.2.2 Tissue Engineering
3.2.3 Gene Therapy
3.2.4 Small Molecule

4. Market Analysis
4.1 Market Sizing (Actual & Forecasted)
4.2 Market Share Analysis
4.2.1 Market Share by Therapy
4.2.2 Market Share by Material
4.2.3 Market Share by Therapeutic Application
4.2.4 Market Share by End-User
4.2.5 Market Share by Region

5. Market Segmentation
5.1 Cell Therapy
5.1.1 Market Sizing (Actual & Forecasted)
5.1.2 Market Share by Region
5.2 Tissue Engineering
5.2.1 Market Sizing (Actual & Forecasted)
5.2.2 Market Share by Region
5.3 Gene Therapy
5.3.1 Market Sizing (Actual & Forecasted)
5.3.2 Market Share by Application
5.3.3 Market Share by Region

6. Regional Analysis
6.1 North America
6.1.1 Market Sizing (Actual &Forecasted)
6.1.2 The US
6.1.2.1   Market Sizing (Actual & Forecasted)
6.1.2.1   Market Share by End-User
6.2 Europe
6.2.1 Market Sizing (Actual &Forecasted)
6.2.2 The UK
6.2.2.1   Market Sizing (Actual & Forecasted)
6.2.2.2   Market Share by Product Type
6.3 Asia Pacific
6.3.1 Market Sizing (Actual &Forecasted)
6.3.2 Japan
6.3.2.1   Market Sizing (Actual & Forecasted)

7. Market Dynamics
7.1 Industry Trends & Developments
7.1.1 Dominance of Dermatology Segment
7.1.2 Adoption of 3D Bioprinting
7.1.3 Use of Nanomaterial for Tissue Regeneration
7.1.4 Higher Investments in Niche Therapies
7.2 Growth Drivers
7.2.1 Prevalence of Chronic Diseases
7.2.2 Rise in Number of Trauma Cases
7.2.3 Organ Shortages
7.2.4 Increasing Incidence of Cancer
7.2.5 Growing Geriatric Population
7.2.6 Increasing R&D Investment
7.3 Challenges
7.3.1 Expensive Treatment Cost
7.3.2 Stringent Regulatory Compliance

8. Competitive Landscape
8.1 Financial Analysis
8.2 Market Share Analysis

9. Company Profiles
9.1 Integra LifeSciences Corporation
9.2 Merck & Co., Inc.
9.3 Stryker Corporation
9.4 Organogenesis Inc.
9.5 Vericell Corporation
9.6 MiMedx Group, Inc.

List of Figures
Figure 1: Research Methodology
Figure 2: Steps of Regenerative Medicine
Figure 3: Global Regenerative Medicine Market Size by Value, 2016-25E (US$ Billions)
Figure 4: Global Regenerative Medicine Market Share by Therapy (2018)
Figure 5: Global Regenerative Medicine Market Share by Material (2018)
Figure 6: Global Regenerative Medicine Market Share by Application (2018)
Figure 7: Global Regenerative Medicine Market Share by End-User (2018)
Figure 8: Global Regenerative Medicine Market Share by Region (2018)
Figure 9: Global Regenerative Medicine – Cell Therapy Market Size by Value, 2017-25E (US$ Billions)
Figure 10: Global Regenerative Medicine – Cell Therapy Market Share by Region (2018)
Figure 11: Global Regenerative Medicine – Tissue Engineering Market Size by Value, 2017-25E (US$ Billions)
Figure 12: Global Regenerative Medicine – Tissue Engineering Market Share by Region (2018)
Figure 13: Global Regenerative Medicine – Gene Therapy Market Size by Value, 2017-25E (US$ Billions)
Figure 14: Global Regenerative Medicine – Gene Therapy Market Share by Application (2018)
Figure 15: Global Regenerative Medicine – Gene Therapy Market Share by Region (2018)
Figure 16: North America Regenerative Medicine Market Size by Value, 2017-25E (US$ Billions)
Figure 17: The US Regenerative Medicine Market Size by Value, 2017-25E (US$ Billions)
Figure 18: The US Regenerative Medicine Market Share by End-User (2018)
Figure 19: Europe Regenerative Medicine Market Size by Value, 2017-25E (US$ Billions)
Figure 20: The UK Regenerative Medicine Market Size by Value, 2017-25E (US$ Billions)
Figure 21: The UK Regenerative Medicine Market Share by Product Type (2018)
Figure 22: Asia Pacific Regenerative Medicine Market Size by Value, 2017-25E (US$ Billions)
Figure 23: Japan Regenerative Medicine Therapy Pipeline, 2000-17
Figure 24: Japan Regenerative Medicine Market Size by Value, 2017-25E (US$ Billions)
Figure 25: Japan Regenerative Medicine - Cell Therapy Market Size by Value, 206-25E (US$ Millions)
Figure 26: Chronic Diseases Prevalence in the US, 2010-30E (Millions)
Figure 27: Global Trauma Cases Incidences, 2013-18 (Millions)
Figure 28: The US Organ Transplant Data, 2003-2015
Figure 29: Transplant Procedure by Age (2017)
Figure 30: Global Ageing (Aged above 65 Years) Population, 2012-18 (Millions)
Figure 31: Global Regenerative Medicine Market Share by Companies (2018)
Figure 32: Integra LifeSciences Corporation Revenue by Business Segment (FY2018)
Figure 33: Integra LifeSciences Corporation Net Sales, FY2015-FY2018 (US$ Billions)
Figure 34: Merck & Co., Inc. Revenue by Business Segment (FY2018)
Figure 35: Merck & Co., Inc. Net Sales, FY2015-FY2018 (US$ Billions)
Figure 36: Stryker Corporation Revenue by Business Segment (FY2018)
Figure 37: Stryker Corporation Net Sales, FY2015-FY2018 (US$ Billions)
Figure 38: Organogenesis Inc. Revenue by Business Segment (FY2018)
Figure 39: Organogenesis Inc. Net Sales, FY2015-FY2018 (US$ Billions)
Figure 40: Vericell Corporation Revenue by Business Segment (FY2018)
Figure 41: Vericell Corporation Net Sales, FY2015-FY2018 (US$ Millions)
Figure 42: MiMedx Group, Inc. Revenue by Business Segment (FY2018)
Figure 43: MiMedx Group, Inc. Net Sales, FY2015-FY2018 (US$ Millions)

List of Tables
Table 1: Incidence of Common Types of Cancer and Estimated Deaths (2017)
Table 2: Global Regenerative Medicine Companies – Financial Analysis (2018)
Table 3: Global Regenerative Medicine Companies – Forecasted Revenue Comparison, 2018-2022E)
Table 4: Organogenesis Inc. Drugs Clinical Pipeline
Table 5: Apligraf Clinical Pipeline

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Integra LifeSciences Corporation
  • Merck & Co. Inc.
  • MiMedx Group Inc.
  • Organogenesis Inc.
  • Stryker Corporation
  • Vericell Corporation
Note: Product cover images may vary from those shown
Adroll
adroll